Luxembourg's laboratories have, unsurprisingly, fared well against the backdrop of the global covid-19 pandemic. Indeed, for 2020, the three Luxembourg market players all published a profit in the Register of Companies, albeit with pronounced differences.
For example, Laboratoires Réunis, which won the large scale testing contract, saw its annual result multiply by more than 11 to reach €15.5m. With 49 sites listed on its website and 198 employees at the end of the last financial year, the Junglinster-based laboratory is not, however, the largest employer in the sector: its competitor Ketterthill has 280 employees, an annual increase of 8%.
The Belval-based laboratory, with 62 locations, reported a 62% increase in net profit to €10.6m.
Only Bionext Lab reported a contraction in its 2020 annual result, with €4.7 million, or 4.8% less than in 2019. Its workforce has nevertheless grown by 10% to 170 employees at around fifty sites.
Its boss and founder, Dr. Jean-Luc Dourson, announced in mid-September that he was taking the Luxembourg government to court over the large-scale testing market awarded to his competitor Laboratoires Réunis.
Read also
This story was first published in French on . It has been translated and edited for Delano.